Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 41 results.
User Information
Export Records
  1. 1.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 2.   Functionally diverse thymic medullary epithelial cells interplay to direct central tolerance
  2. Ushio, Aya; Matsuda-Lennikov, Mami; Kalle-Youngoue,Felix; Shimizu, Akihide; Abdelmaksoud, Abdalla; Kelly, Michael C; Ishimaru, Naozumi; Takahama, Yousuke
  3. Cell Reports. 2024, Apr 05; 43(4): 114072.
  1. 3.   Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
  2. Zhu, Lan; Zhang, Xiangyan; Chen, Xin; Yang,De; Nie, Yujie; Pan, Runsang; Li, Linzhao; Wang, Chenglv; Gui, Huan; Chen, Shuanghui; Jing, Qianyu; Wang, Mengjiao; Nie, Yingjie
  3. Biochemical and Biophysical Research Communications. 2023, Feb 16; 653: 106-114.
  1. 4.   A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer
  2. Jiang, Mengmeng; Liu,Jia; Yang,De; Tross,Debra; Li, Ping; Chen, Fengyang; Alam,Md Masud; Faustman, Denise L; Oppenheim,Joost; Chen, Xin
  3. International immunopharmacology. 2021, Nov 15; 101(Pt A): 108345.
  1. 5.   Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE
  2. Tanwar, Shalini; Oguz,Cihan; Metidji, Amina; Dahlstrom, Eric; Barbian, Kent; Kanakabandi, Kishore; Sykora, Lydia; Shevach, Ethan M
  3. Journal of autoimmunity. 2020, DEC; 115: 102525.
  1. 6.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 7.   Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients with Early Lyme Disease Reveals Predominant Interferon Signaling
  2. Marques, Adriana; Schwartz, Ira; Wormser, Gary P; Wang, Yanmei; Hornung, Ronald L; Demirkale, Cumhur Y; Munson, Peter J; Turk, Siu-Ping; Williams, Carla; Lee, Chyi-Chia Richard; Yang, Jun; Petzke, Mary M
  3. Journal of Infectious Diseases. 2018, Jan 1; 217(1): 158-167.
  1. 8.   CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
  2. McGary, Colleen S; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jake; Sekaly, Rafick-Pierre; Paiardini, Mirko
  3. Immunity. 2017, Oct 17; 47(4): 776-788.e5.
  1. 9.   ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans
  2. Lyons, J. J.; Liu, Y.; Ma, C. A.; Yu, X.; O'Connell, M. P.; Lawrence, M. G.; Zhang, Y.; Karpe, K.; Zhao, M.; Siegel, A. M.; Stone, K. D.; Nelson, C.; Jones, Nina; DiMaggio, T.; Darnell, D. N.; Mendoza-Caamal, E.; Orozco, L.; Hughes, J. D.; McElwee, J.; Hohman, R. J.; Frischmeyer-Guerrerio, P. A.; Rothenberg, M. E.; Freeman, A. F.; Holland, S. M.; Milner, J. D.
  3. JOURNAL OF EXPERIMENTAL MEDICINE. 2017, 2017-03-01; 214(3): 669-680.
  1. 10.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 11.   Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
  2. Chen, X.; Oppenheim, J. J.
  3. Febs Letters. 2011, Dec; 585(23): 3611-3618.
  1. 12.   Highlights of 10 years of immunology in Nature Reviews Immunology
  2. Medzhitov, R.; Shevach, E. M.; Trinchieri, G.; Mellor, A. L.; Munn, D. H.; Gordon, S.; Libby, P.; Hansson, G. K.; Shortman, K.; Dong, C.; Gabrilovich, D.; Gabrysova, L.; Howes, A.; O'Garra, A.
  3. Nature Reviews Immunology. 2011, Oct; 11(10): 693-702.
  1. 13.   Resolving the identity myth: Key markers of functional CD4(+)FoxP3(+) regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. International Immunopharmacology. 2011, Oct; 11(10): 1489-1496.
  1. 14.   The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Immunology. 2011, Aug; 133(4): 426-433.
  1. 15.   Nitric oxide and redox mechanisms in the immune response
  2. Wink, D. A.; Hines, H. B.; Cheng, R. Y. S.; Switzer, C. H.; Flores-Santana, W.; Vitek, M. P.; Ridnour, L. A.; Colton, C. A.
  3. Journal of Leukocyte Biology. 2011, Jun; 89(6): 873-891.
  1. 16.   At 17, In-10's Passion Need Not Inflame
  2. Stewart, C. A.; Trinchieri, G.
  3. Immunity. 2011, Apr; 34(4): 460-462.
  1. 17.   Hypoxia Potentiates Glioma-Mediated Immunosuppression
  2. Wei, J.; Wu, A.; Kong, L. Y.; Wang, Y. T.; Fuller, G.; Fokt, I.; Melillo, G.; Priebe, W.; Heimberger, A. B.
  3. Plos One. 2011, Jan; 6(1): 12.
  1. 18.   Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
  2. Yu, P.; Steel, J. C.; Zhang, M. L.; Morris, J. C.; Waldmann, T. A.
  3. Clinical Cancer Research. 2010, Dec; 16(24): 6019-6028.
  1. 19.   Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
  2. Shurin, M. R.; Gregory, M.; Morris, J. C.; Malyguine, A. M.
  3. Expert Opinion on Biological Therapy. 2010, Nov; 10(11): 1539-1553.
  1. 20.   Serum Cytokine Analysis in a Positive Chemoprevention Trial: Selenium, Interleukin-2, and an Association with Squamous Preneoplastic Disease
  2. Roth, M. J.; Katki, H. A.; Wei, W. Q.; Qiao, Y. L.; Bagni, R.; Wang, G. Q.; Whitby, D.; Dong, Z. W.; Gail, M. H.; Limburg, P. J.; Giffen, C. A.; Taylor, P. R.; Dawsey, S. M.
  3. Cancer Prevention Research. 2010, Jul; 3(7): 810-817.
  1. 21.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 22.   Cancer and Inflammation: Promise for Biologic Therapy
  2. Demaria, S.; Pikarsky, E.; Karin, M.; Coussens, L. M.; Chen, Y. C.; El-Omar, E. M.; Trinchieri, G.; Dubinett, S. M.; Mao, J. T.; Szabo, E.; Krieg, A.; Weiner, G. J.; Fox, B. A.; Coukos, G.; Wang, E.; Abraham, R. T.; Carbone, M.; Lotze, M. T.
  3. Journal of Immunotherapy. 2010, May; 33(4): 335-351.
  1. 23.   Co-expression of TNFR2 and CD25 identifies more of the functional CD4(+)FOXP3(+) regulatory T cells in human peripheral blood
  2. Chen, X.; Subleski, J. J.; Hamano, R.; Howard, O. M. Z.; Wiltrout, R. H.; Oppenheim, J. J.
  3. European Journal of Immunology. 2010, Apr; 40(4): 1099-1106.
  1. 24.   Rapamycin Protects Mice from Staphylococcal Enterotoxin B-Induced Toxic Shock and Blocks Cytokine Release In Vitro and In Vivo
  2. Krakauer, T.; Buckley, M.; Issaq, H. J.; Fox, S. D.
  3. Antimicrobial Agents and Chemotherapy. 2010, Mar; 54(3): 1125-1131.
  1. 25.   Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells
  2. Mannon, P. J.; Leon, F.; Fuss, I. J.; Walter, B. A.; Begnami, M.; Quezado, M.; Yang, Z.; Yi, C.; Groden, C.; Friend, J.; Hornung, R. L.; Brown, M.; Gurprasad, S.; Kelsall, B.; Strober, W.
  3. Clinical and Experimental Immunology. 2009 155(3): 447-456.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel